These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

422 related articles for article (PubMed ID: 19421930)

  • 1. [Intensive blood glucose lowering to reduce cardiovascular risk: contra].
    Marx N
    Dtsch Med Wochenschr; 2009 May; 134(20):1061. PubMed ID: 19421930
    [No Abstract]   [Full Text] [Related]  

  • 2. [Intensive blood glucose lowering to reduce cardiovascular risk: pro].
    Martin S
    Dtsch Med Wochenschr; 2009 May; 134(20):1060. PubMed ID: 19421929
    [No Abstract]   [Full Text] [Related]  

  • 3. Does intensive glycemic control improve cardiovascular outcomes?
    Pendergrass M
    Nat Clin Pract Endocrinol Metab; 2008 Oct; 4(10):529. PubMed ID: 18806805
    [No Abstract]   [Full Text] [Related]  

  • 4. [World news in age-related diabetes: blood sugar lowering can improve prognosis].
    Einecke D
    MMW Fortschr Med; 2005 Sep; 147(38):1. PubMed ID: 16218218
    [No Abstract]   [Full Text] [Related]  

  • 5. [Acarbose--an effective drug for the prevention of type 2 diabetes and cardiovascular diseases?].
    Laakso M
    Duodecim; 2003; 119(20):1921-3. PubMed ID: 14639996
    [No Abstract]   [Full Text] [Related]  

  • 6. [The effect of glitazones on the progression of type 2 diabetes and on cardiovascular endpoints].
    Schatz H
    Dtsch Med Wochenschr; 2005 Aug; 130(31-32):1825-30. PubMed ID: 16052448
    [No Abstract]   [Full Text] [Related]  

  • 7. Metformin: diamonds are forever.
    Papanas N; Maltezos E; Mikhailidis DP
    Expert Opin Pharmacother; 2009 Oct; 10(15):2395-7. PubMed ID: 19678795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Opinion: Tight blood glucose control and cardiovascular disease in the elderly diabetic? Let the randomized controlled trials speak for themselves.
    Sherman FT
    Geriatrics; 2008 Aug; 63(8):8-10. PubMed ID: 18672951
    [No Abstract]   [Full Text] [Related]  

  • 9. From hyperglycemia to the risk of cardiovascular disease.
    Leiter LA
    Rev Cardiovasc Med; 2006; 7 Suppl 2():S3-9. PubMed ID: 17224875
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does lowering of blood glucose improve cardiovascular morbidity and mortality?
    Iqbal N; Rubenstein AH
    Clin J Am Soc Nephrol; 2008 Jan; 3(1):163-7. PubMed ID: 18178783
    [No Abstract]   [Full Text] [Related]  

  • 11. Type 2 diabetes treatment and macrovascular complications--fat and sugar make a dangerous soufflé.
    Bajaj M; Jialal I
    Metab Syndr Relat Disord; 2009 Apr; 7(2):79-81. PubMed ID: 19351292
    [No Abstract]   [Full Text] [Related]  

  • 12. Improved knowledge of antidiabetic treatment--a necessity for the modern cardiologist.
    Wikström G; Malmberg K; Rydén L
    Eur Heart J; 1999 Mar; 20(6):403-5. PubMed ID: 10213343
    [No Abstract]   [Full Text] [Related]  

  • 13. [Anti-diabetic treatment, insulin resistance and cardiovascular disease in patients with type 2 diabetes].
    Hemmingsen B; Lund SS; Vaag A
    Ugeskr Laeger; 2009 May; 171(19):1598-602. PubMed ID: 19419642
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cardiovascular effects and safety of glucose-lowering drugs: current situation].
    Masmiquel L
    Semergen; 2014 Mar; 40(2):80-8. PubMed ID: 24655910
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cardioprotection by acarbose--contra].
    Kaiser T; Sawicki PT
    Dtsch Med Wochenschr; 2004 May; 129(20):1156. PubMed ID: 15143460
    [No Abstract]   [Full Text] [Related]  

  • 16. Associated atherothrombotic disease risk factors in diabetes and prediabetes.
    Feeman WE
    Am J Med; 2006 May; 119(5):e19. PubMed ID: 16651039
    [No Abstract]   [Full Text] [Related]  

  • 17. STOP-NIDDM: a new paradigm for diabetes prevention?
    Hanefeld M
    Nutr Metab Cardiovasc Dis; 2002 Oct; 12(5):253-8. PubMed ID: 12616804
    [No Abstract]   [Full Text] [Related]  

  • 18. [Glitazones critically evaluated].
    Schernthaner G
    Dtsch Med Wochenschr; 2007 Dec; 132(49):2619. PubMed ID: 18050024
    [No Abstract]   [Full Text] [Related]  

  • 19. Treatment of type 2 diabetes: one extreme to another.
    Zaidi S
    Arch Intern Med; 2009 Jul; 169(13):1246-7; author reply 1247. PubMed ID: 19597079
    [No Abstract]   [Full Text] [Related]  

  • 20. [Too positive comment on glitazones].
    Lindberg M
    Ugeskr Laeger; 2007 Feb; 169(8):733; author reply 733. PubMed ID: 17338040
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 22.